Anzeige von Arzneimittelentwicklung zu vernachlässigten Krankheiten | TATuP Zeitschrift für Technikfolgenabschätzung in Theorie und Praxis

From Google Translate: "Diseases that occur almost exclusively in poor countries have been neglected in medical research and development for decades. One reason is seen in low-demand demand. It can not sufficiently stimulate the complex commercialized product development. For a number of years, attempts have been made to mitigate the systemic problem of the patent-based innovation process, at least in the case of poverty-related diseases. Some stakeholders test the extent to which a basic idea of ​​open source software development - the collaboration of volunteers brings out products that are not owned by any company - is transferred to the development of the drug. To this end, they open up various elements of the pharmacological innovation process for sharing and further development. They call this partly Open Innovation. The article presents relevant initiatives."